先声药业集团有限公司（香港注册成立，股份代码：02096）于2026年1月6日发布截至2025年12月31日的股份变动月报表。报告期内，公司已发行及库存股份数目无新增发行、购回或注销，普通股本月底结存与上月底保持一致，为2,595,697,618股。
根据公告，公司现行的限制性股份单位计划于2023年6月15日修订并重列，并曾于2025年12月1日授出15,408,100份限制股份单位，惟当月并未导致股份实际增发。公告由执行董事及联席公司秘书万玉山签署，公司确认遵守香港联交所上市规则及相关法律法规，截至12月底公司股本维持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.